Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera

Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节

基本信息

  • 批准号:
    8885647
  • 负责人:
  • 金额:
    $ 72.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-09 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Epidemiologic studies demonstrate that DMPA may increase the risk of HIV acquisition and transmission. Additionally, Depo-Provera has been shown to attenuate the vaccine efficacy to protect rhesus macaques against SIV infection. The impact of hormonal contraceptive use on HIV acquisition and transmission has profound implications for polices on family planning, particularly in countries with high rates of HIV transmission. While progesterone clearly enhances vaginal transmission of SIV/SHIV in rhesus macaques, the effect of progestin-based hormone on HIV acquisition/transmission in women remains unresolved. We hypothesize that injectable DMPA alters immune responses and cervicovaginal and colonic microbiomes, which may lead to increased HIV acquisition and transmission. The aims of this proposal are designed to (1) determine the impact of Depo-Provera on the systemic and mucosal immune systems and on cervicovaginal and colonic microbiomes in a longitudinal study, and (2) to elucidate the immune mechanisms of MPA-mediated modulation of HIV infection/transmission in vitro, ex vivo and in cervical explant models. Blood, cervicovaginal specimens and stool samples will be collected at baseline (both follicular and luteal phases) and after 4, and 8 weeks of DMPA injection. The immunological profiles of CD4+ T cells and their susceptibility to HIV will be characterized. We will determine the temporal impact of DMPA on cervicovaginal and colonic microbiome. Global alteration and changes in specific taxa will be correlated with immunological changes. The results of our studies will provide a better understanding of how DMPA modulates immunologic responses and microbiomes, thereby informing the design of effective HIV prevention strategies.
描述(由申请人提供):流行病学研究表明 DMPA 可能会增加 HIV 感染和传播的风险。此外,Depo-Provera 已被证明会减弱疫苗保护恒河猴免受 SIV 感染的功效。激素避孕药的使用对艾滋病毒感染和传播的影响对计划生育政策具有深远的影响,特别是在艾滋病毒传播率高的国家。虽然孕激素明显增强了恒河猴中 SIV/SHIV 的阴道传播,但基于孕激素的激素对女性 HIV 获得/传播的影响仍未解决。我们假设注射 DMPA 会改变免疫反应以及宫颈阴道和结肠微生物群,这可能导致 HIV 感染和传播增加。该提案的目的是(1)在纵向研究中确定 Depo-Provera 对全身和粘膜免疫系统以及宫颈阴道和结肠微生物组的影响,以及(2)阐明体外、离体和宫颈外植体模型中 MPA 介导的 HIV 感染/传播调节的免疫机制。将在基线(卵泡期和黄体期)以及 DMPA 注射 4 周和 8 周后收集血液、宫颈阴道标本和粪便样本。 CD4+ T 细胞的免疫学特征及其对 HIV 的易感性将得到表征。我们将确定 DMPA 对宫颈阴道和结肠微生物群的暂时影响。特定分类群的整体改变和变化将与免疫学变化相关。我们的研究结果将有助于更好地了解 DMPA 如何调节免疫反应和微生物组,从而为有效的 HIV 预防策略的设计提供信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Theresa L Chang其他文献

Theresa L Chang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Theresa L Chang', 18)}}的其他基金

Sex difference in intestinal immune dysfunction, SHIV infection and reservoir
肠道免疫功能障碍、SHIV感染和储存者的性别差异
  • 批准号:
    10654740
  • 财政年份:
    2021
  • 资助金额:
    $ 72.18万
  • 项目类别:
Impact of gender affirming hormone therapy on immune modulation and HIV infection in transgender young adults
性别肯定激素治疗对跨性别年轻人免疫调节和艾滋病毒感染的影响
  • 批准号:
    10364706
  • 财政年份:
    2021
  • 资助金额:
    $ 72.18万
  • 项目类别:
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir
肠道免疫功能障碍、SHIV感染和储存者的性别差异
  • 批准号:
    10462764
  • 财政年份:
    2021
  • 资助金额:
    $ 72.18万
  • 项目类别:
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir
肠道免疫功能障碍、SHIV感染和储存者的性别差异
  • 批准号:
    10327456
  • 财政年份:
    2021
  • 资助金额:
    $ 72.18万
  • 项目类别:
Impact of gender affirming hormone therapy on immune modulation and HIV infection in transgender young adults
性别肯定激素治疗对跨性别年轻人免疫调节和艾滋病毒感染的影响
  • 批准号:
    10257722
  • 财政年份:
    2021
  • 资助金额:
    $ 72.18万
  • 项目类别:
Role of IFNe in immune modulation and HIV infection
IFNe在免疫调节和HIV感染中的作用
  • 批准号:
    10356898
  • 财政年份:
    2018
  • 资助金额:
    $ 72.18万
  • 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
  • 批准号:
    9045100
  • 财政年份:
    2013
  • 资助金额:
    $ 72.18万
  • 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
  • 批准号:
    8716673
  • 财政年份:
    2013
  • 资助金额:
    $ 72.18万
  • 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
  • 批准号:
    8593906
  • 财政年份:
    2013
  • 资助金额:
    $ 72.18万
  • 项目类别:
HIV-Human Peritonal Macrophage Interactions
HIV-人腹膜巨噬细胞相互作用
  • 批准号:
    8232027
  • 财政年份:
    2011
  • 资助金额:
    $ 72.18万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 72.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 72.18万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 72.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 72.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 72.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 72.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 72.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 72.18万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 72.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 72.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了